Target intelligence / Profile preview

Keratinocyte cell turnover

Molecular classification
Other
01

Overview

Keratinocyte cell turnover refers to the continuous process in which keratinocyte stem cells divide in the basal layer of the epidermis, differentiate as they migrate toward the surface, and eventually undergo terminal differentiation and programmed cell death to form the stratum corneum[2][4][1][3][6]. This process is vital for maintaining skin integrity, barrier function, and resistance to environmental insults. Disruption of keratinocyte turnover is implicated in numerous dermatological diseases, aging, and impaired wound healing[1][2][6]. The rate of keratinocyte renewal decreases with age and may be modulated by topical drugs used in dermatology[4][6]. Note: "Keratinocyte cell turnover" is a biological process, not a specific molecular entity (e.g., receptor, enzyme, or transporter), so precise annotation per your target structure is not applicable. For molecular targeting, consider specific proteins or pathways regulating this process, such as Epidermal growth factor receptor (EGFR), Notch signaling components, or ΔNp63α[3][5].

Other names
keratinocyte lifecycleepidermal cell turnoverskin cell renewalkeratinocyte differentiationepidermal renewal
02

Mechanism of action

Modulation of keratinocyte proliferation/differentiation; Induction of apoptosis in abnormal cells; Enhancement of cell shedding from the stratum corneum

03

Biological functions

Barrier formationSkin renewalCell proliferationCell differentiationApoptosisCornificationWound healing
04

Disease associations

Skin disorders (e.g., psoriasis, eczema, ichthyosis, aging skin)Wound healing impairmentCancer (keratinocyte-derived carcinomas)Inflammation
05

Safety considerations

Skin irritationBarrier dysfunction/increased permeabilityInfection risk with excessive exfoliation
06

Interacting drugs

Topical retinoids (stimulate turnover)

4 more in the full profile.

07

Biomarkers

Keratin 1, Keratin 10 (markers of differentiation)Ki-67 (marker of proliferation)Filaggrin, involucrin, loricrin (differentiation markers)

Beyond the preview

Go deeper on Keratinocyte cell turnover.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratinocyte cell turnover.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call